Search

Skip to main content Multi-modality Molecular Imaging Non-invasive imaging has transformed pre-clinical studies of physiology, pharmacology, and drug development. Novel instrumentation together with reporter molecules and strategies have provided new insights into disease progression and response to …

Information about James Kim Research Lab

Learn about Mason Lab's Tumor Hypoxia research.

Westover Lab facilities.

Westover Lab patents.

Learn about Mason Lab's Novel Reporter Agents research.

Skip to main content Lung Cancer Therapy Optimizing Therapeutic Strategies Against Lung Cancer Using Multi-Modality Imaging Despite improved early detection and the use of targeted therapies and immunotherapies, the lung cancer 5-year survival rate remains 10-20% in most countries. Tumor hypoxia, i.e…

Westover Lab news.

Westover Lab publications.

Orson Moe is a physician-scientist who specializing in studies in disease-oriented pre-clinical pathophysiology in kidney-related topics.  The studies are focus on metabolism and epithelial transport physiology and pathophysiology.  The clinically relevant topics are acute kidney injury, chronic kidney disease, extra-renal complications of kidney disease, and kidney stones. In the laboratory, students and post-docs assume central roles in conducting their studies and their training are matched to their projected scientific career trajectories.  In addition to being a clinician-laboratory scientist, Moe is also active in education in basic and clinical science on campus and at the national and international levels.